4//SEC Filing
Harrison Danika R 4
Accession 0001548187-21-000075
CIK 0001548187other
Filed
Dec 16, 7:00 PM ET
Accepted
Dec 17, 5:07 PM ET
Size
9.9 KB
Accession
0001548187-21-000075
Insider Transaction Report
Form 4
Soliton, Inc.SOLY
Harrison Danika R
Director
Transactions
- Disposition to Issuer
Stock option (right to buy)
2021-12-16−30,000→ 0 totalExercise: $1.75Exp: 2028-06-19→ Common Stock (30,000 underlying) - Disposition to Issuer
Stock option (right to buy)
2021-12-16−15,000→ 0 totalExercise: $14.62Exp: 2029-06-27→ Common Stock (15,000 underlying) - Disposition to Issuer
Stock option (right to buy)
2021-12-16−15,000→ 0 totalExercise: $12.94Exp: 2030-06-19→ Common Stock (15,000 underlying)
Footnotes (1)
- [F1]Pursuant to the Agreement and Plan of Merger, dated as of May 8, 2021 (the "Merger Agreement"), by and among Soliton, Inc. (the "Company"), AbbVie Inc. ("AbbVie") and Scout Merger Sub, Inc., a wholly owned subsidiary of AbbVie ("Merger Sub"), immediately prior to the effective time of the merger of Merger Sub with and into the Company (the "Merger"), each outstanding and unexercised option, whether vested or unvested, was converted into the right to receive a cash payment, without interest and subject to deduction for any required withholding under applicable law, in an amount equal to $22.60 (the "Merger Consideration") minus the exercise price that would be due in cash upon exercise of such option.
Documents
Issuer
Soliton, Inc.
CIK 0001548187
Entity typeother
Related Parties
1- filerCIK 0001547535
Filing Metadata
- Form type
- 4
- Filed
- Dec 16, 7:00 PM ET
- Accepted
- Dec 17, 5:07 PM ET
- Size
- 9.9 KB